Navigation Links
Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
Date:8/21/2007

Randomized, Double-Blind Study Targets Biomarker-Defined Population

BERKELEY HEIGHTS, N.J., Aug. 21 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced that the first patients have been enrolled in the Company's confirmatory Phase 3 trial of Genasense (oblimersen sodium) Injection in advanced melanoma. The trial, known as AGENDA, is a randomized, double-blind, placebo-controlled study in which patients are randomly assigned to receive Genasense plus dacarbazine (DTIC) or DTIC alone. AGENDA will accrue approximately 300 patients and will be conducted at approximately 100 sites worldwide, including North America, Europe and Australia. Accrual is expected to take approximately 18 months, with initial data expected shortly thereafter.

AGENDA is designed to confirm the safety and efficacy of Genasense when combined with DTIC in patients who have not previously received chemotherapy. Genta's prior Phase 3 trial of this drug combination had shown that maximal benefit occurred in patients with normal baseline LDH, a blood enzyme that strongly correlates with outcome. The AGENDA study is limited to patients whose baseline LDH is less than 0.8 times the upper limit of normal. Analysis of that trial suggested that patients in this group achieved a significantly superior outcome (see table below).

"Genasense plus dacarbazine yielded superior results in a large randomized trial," said Dr. Agop Bedikian, Professor of Medicine at the M.D. Anderson Cancer Center, Houston, TX, who was the lead author on the publication of the previous Genasense trial. "Our center is pleased to have entered the first patient onto this important new study that seeks to extend those initial results using a biomarker t
'/>"/>

SOURCE Genta Incorporated

Copyright©2007 PR Newswire.

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Malvern initiates European user group meetings for chemical imaging
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony Biotechnology ... Cell Sorter 8-well strip holder and 130um sorting chip.  Sony ... data collected on its new SH800 Cell Sorter, the EC800 ... during commercial tutorials at CYTO 2013, which will be held ... in San Diego, California , from May ...
(Date:5/17/2013)... NEW YORK , May 17, 2013 /PRNewswire-iReach/ -- ... for Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life ... offering free PALS, BLS and ACLS online ... free manuals, people simply need to build an account ... review materials for these programs, United Medical Education is ...
(Date:5/17/2013)... 2013  TechAtlas Group has announced the release ... map for the Chronic Kidney Disease (CKD) market. ... with drugs and devices currently on the market ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... - renal denervation , diabetic nephropathy - ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... N.C., July 20, 2011 Chimerix, Inc., a biotechnology ... Painter, Ph.D., Chairman of the Board and Chief Scientific ... Annual Biodefense Vaccines & Therapeutics Conference on July 22nd, ... at the Almas Temple Club in Washington, D.C. on ...
... July 20, 2011 A new online resource, ... law enforcement, and community organizations combat the illegal diversion ... Pharma L.P . has developed RxSafetyMatters.org to ... organizations with which it is partnering to help deter ...
Cached Medicine Technology:Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 2Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 3New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P. 2New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P. 3
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 John Ravera, ... announced the addition of a new member to his dental ... has worked in the field for over 10 years. She ... with honors, and was elected a member of Sigma Pi ... hygiene profession. Marino enjoys working with patients of all ages, ...
(Date:5/18/2013)... San Diego, CA (PRWEB) May 18, 2013 ... In its latest update to consumers about ... consolidated in federal court Resource4thePeople reports that ... litigation, according to court documents. , The ... in U.S. District Court in the Southern ...
(Date:5/18/2013)... Vegas, Nevada (PRWEB) May 18, 2013 ... Cambogia Extract weight loss supplement, which features unmatched potency ... , “Creation's Gold was set up to provide the ... as they work to achieve their wellness goals. The ... need to lead happier, healthier lives. We started by ...
(Date:5/17/2013)... May 18, 2013. Chronic trauma can inflict lasting damage ... imaging studies of people with post-traumatic stress disorder, or ... under-react in response to stressful tasks, such as recalling ... a threatening face. Now, researchers at NYU School of ... in the brains of combat veterans with PTSD in ...
(Date:5/17/2013)... Daily Gossip announced on Monday that their reporters ... Program Yourself Thin regime, Jim Katsoulis. , ... the end of the month in order to teach readers ... and lead a healthy lifestyle, free of food cravings and ... is available for only $97 and it comes with six ...
Breaking Medicine News(10 mins):Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... and choose certain brands, experts note , , THURSDAY, ... reaching teenagers and influencing their desire to smoke and ... "We are continuing to find that Marlboro, Newport and ... to be overwhelmingly the preferred brands of cigarettes smoked ...
... With the goal of advancing the lives,of children and ... Ski and Snowboard Program hit the slopes last weekend. ... on,Saturday, Feb. 7, for a day of fun, competition ... ski race. , The event, ...
... art of sleep with Sleep Concierge consultation and other Dreamy Perks ... ... of a sleepless night - jet-lag, a new baby, a plummeting portfolio ... National Sleep Foundation, costs companies more than $100 billion annually in reduced ...
... 12 /PRNewswire-USNewswire/ - - A new report on ... students demonstrates the need for Congress to give the ... tobacco, Partnership for Prevention Interim President Corinne G. Husten, ... brand of cigarettes in history is also the favorite ...
... Feb. 12 Today, the Medicaid Health Plans ... focused on representing Medicaid health plans, applauded House and ... American Recovery and Reinvestment Act Conference Report that will ... "The Medicaid provisions in this agreement will allow states ...
... released today by Every Child By Two:The U.S. Court ... over the causes of autism. The three judges ... with thimerosal-containing vaccines, does not cause autism. The ... have failed to show a link between vaccines and ...
Cached Medicine News:Health News:Tobacco Companies Targeting Teens, Study Says 2Health News:Tobacco Companies Targeting Teens, Study Says 3Health News:Tobacco Companies Targeting Teens, Study Says 4Health News:Second Annual Courage Cup Race Raises More Than $5,000 for Courage Center's Ski and Snowboard Program 2Health News:The Benjamin Marks National Sleep Awareness Week With Introduction Of "The Sleep Retreat" 2Health News:The Benjamin Marks National Sleep Awareness Week With Introduction Of "The Sleep Retreat" 3Health News:Partnership for Prevention: CDC Report Shows Compelling Need for FDA Regulation of Tobacco 2Health News:Medicaid Health Plans of America Lauds Stimulus Bill's Conference Agreement Which Provides $90 Billion in Medicaid Relief for Nation's Most Vulnerable Citizens 2Health News:Federal Court Declares Vaccines Do Not Cause Autism 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: